What’s New in Newly Diagnosed Multiple Myeloma: Current Concepts, Emerging Approaches

Through a text module, downloadable slides, and an expert written ClinicalThought, gain in-depth knowledge on how to best manage patients with newly diagnosed multiple myeloma, including strategies for mitigating toxicities with multi-drug regimens.

Share

Program Content

Activities

Newly Diagnosed Multiple Myeloma
What’s New in Newly Diagnosed Multiple Myeloma
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 16, 2024

Expires: May 15, 2025

Activities

Newly Diagnosed Multiple Myeloma
What’s New in Newly Diagnosed Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 16, 2024

Expires: May 15, 2025

Activities

Transplant-Eligible Newly Diagnosed MM
Considerations for Transplant-Eligible Newly Diagnosed Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 02, 2024

Expires: May 01, 2025

Faculty

cover img faculity

Charise Gleason, MSN, NP-C, AOCNP

VP and Chief APP Officer
Emory Healthcare
NP Myeloma Program Winship Cancer Institute
Adjunct Faculty
Nell Hodgson Woodruff School of Nursing
Atlanta, Georgia

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange and Clinical Care Options, LLC

Supporters

Supported by an educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner